1. Home
  2. ENSC vs FGI Comparison

ENSC vs FGI Comparison

Compare ENSC & FGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • FGI
  • Stock Information
  • Founded
  • ENSC 2003
  • FGI 1987
  • Country
  • ENSC United States
  • FGI United States
  • Employees
  • ENSC N/A
  • FGI N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • FGI Industrial Specialties
  • Sector
  • ENSC Health Care
  • FGI Industrials
  • Exchange
  • ENSC Nasdaq
  • FGI Nasdaq
  • Market Cap
  • ENSC 5.5M
  • FGI 5.5M
  • IPO Year
  • ENSC N/A
  • FGI 2022
  • Fundamental
  • Price
  • ENSC $2.13
  • FGI $0.92
  • Analyst Decision
  • ENSC
  • FGI
  • Analyst Count
  • ENSC 0
  • FGI 0
  • Target Price
  • ENSC N/A
  • FGI N/A
  • AVG Volume (30 Days)
  • ENSC 84.7K
  • FGI 225.5K
  • Earning Date
  • ENSC 08-13-2025
  • FGI 08-06-2025
  • Dividend Yield
  • ENSC N/A
  • FGI N/A
  • EPS Growth
  • ENSC N/A
  • FGI N/A
  • EPS
  • ENSC N/A
  • FGI N/A
  • Revenue
  • ENSC $6,224,081.00
  • FGI $134,277,102.00
  • Revenue This Year
  • ENSC N/A
  • FGI $7.72
  • Revenue Next Year
  • ENSC $1,381.48
  • FGI $6.94
  • P/E Ratio
  • ENSC N/A
  • FGI N/A
  • Revenue Growth
  • ENSC 256.35
  • FGI 11.13
  • 52 Week Low
  • ENSC $1.62
  • FGI $0.46
  • 52 Week High
  • ENSC $14.67
  • FGI $1.10
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 45.62
  • FGI 67.44
  • Support Level
  • ENSC $1.97
  • FGI $0.64
  • Resistance Level
  • ENSC $2.40
  • FGI $1.10
  • Average True Range (ATR)
  • ENSC 0.17
  • FGI 0.11
  • MACD
  • ENSC -0.00
  • FGI 0.03
  • Stochastic Oscillator
  • ENSC 37.21
  • FGI 79.05

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.

Share on Social Networks: